Skip to main content
. 2022 Apr 4;19:74. doi: 10.1186/s12974-022-02429-7

Table 1.

Demographic and clinical parameters (plus available cortisol data)

Variables FEMD RMD Controls Test Test value p-value p-FEMD/C p-RMD/C p-RMD/FEMD
Age (years) 33.5 (25.0;46.3;82) 42.0 (30.0;52.0;47) 38.0 (28.0;47.5;129) H-test KW = 5.15 0.076 0.214 0.214 0.082
Disease duration (years) 0 (0;0;82) 4.5 (2.0;9.8;32) U-test W = 82.0 < 0.001
Gender (female/male) 43/39 33/14 77/52 Chi-Square χ2 = 3.93 0.140 0.371 0.371 0.221
BMI_T0 23.1 (20.3;25.6;82) 25.0 (21.4;27.6;47) 24.1 (21.8;27.2;129) H-test KW = 6.40 0.041 0.054 0.431 0.054
BMI_T6 24.0 (21.3;27.3;63) 24.8 (22.3;27.8;36) U-test W = 997.5 0.323
Test value W = 494 W = 149
T0–T6 p-value 0.008 0.088
Smoking status (yes/no) 42/40 22/24 29/100 Chi-Square χ2 = 21.22 < 0.001 < 0.001 0.003 0.854
Cigarettes/day-T0 4.5 (0;20.0;82) 0 (0;15;46) 0 (0;0;129) H-test KW = 29.61 < 0.001 < 0.001 < 0.001 0.337
Cigarettes/day-T6 0 (0;15.0;63) 0 (0;14.3;36) U-test W = 1219.0 0.506
Test value W = 109 W = 36.5
T0–T6 p-value 0.129 0.788
AMI-T6 (g) 4.10 (2.81;5.69;54) 3.60 (2.69;6.44;31) U-test W = 801.0 0.853
HAMD-21-T0 19.0 (14.8;23.0;82) 22.0 (15.0;29.0;47) U-test W = 1637.0 0.156
HAMD-21-T6 6.0 (3.0;10.0;63) 8.0 (6.0;13.0;37) U-test W = 760.5 0.004
Test value W = 1759 W = 660
T0–T6 p-value < 0.001 < 0.001
GAF-T0 50.0 (48.5;60.0;80) 50.0 (41.0;60.0;47) U-test W = 2042.0 0.415
GAF-T6 70.0 (65.8;80.8;60) 65.0 (60.0;76.5;37) U-test W = 1398.0 0.032
Test value W = 76.5 W = 35
T0–T6 p-value < 0.001 < 0.001
Cortisol-T0 (ng/mL) 330 (181;713;37) 343 (166;1130;20) 229 (171;853;46) H-test KW = 0.665 0.717 0.823 0.823 0.874
Cortisol-T6 (ng/mL) 212 (140;532;27) 218 (145;818;13) U-test W = 149.5 0.461
Test value W = 318 W = 55
T0–T6 p-value 0.001 0.542

Data are presented as median (quartile 1; quartile 3; sample size) or number of cases

AMI cumulative amitriptyline dosage, HAMD 21-item Hamilton Scale for Depression, GAF Global Assessment of Functioning

Significant p-values are highlighted in bold font